phenylalanine and cgs 25462

phenylalanine has been researched along with cgs 25462 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berry, C; Blanchard, L; De Lombaert, S; el-Chehabi, L; Erion, MD; Ghai, RD; Sakane, Y; Tan, J; Trapani, AJ	1
Cipriano, A; Maniara, WM; Powell, ML	1

Other Studies

2 other study(ies) available for phenylalanine and cgs 25462

Article	Year
N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors. Journal of medicinal chemistry, 1994, Feb-18, Volume: 37, Issue:4 Topics: Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Blood Pressure; Half-Life; Neprilysin; Organophosphonates; Phenylalanine; Phosphopeptides; Prodrugs; Rats; Structure-Activity Relationship	1994
Quantitative analytical methods for the determination of a new hypertension drug, CGS 25462, and its metabolites (CGS 25659 and CGS 24592) in human plasma by high-performance liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications, 1998, Mar-20, Volume: 706, Issue:2 Topics: Administration, Oral; Antihypertensive Agents; Biphenyl Compounds; Chromatography, High Pressure Liquid; Circadian Rhythm; Half-Life; Humans; Male; Organophosphonates; Phenylalanine; Prodrugs; Protease Inhibitors; Reproducibility of Results; Sensitivity and Specificity; Temperature; Time Factors	1998

Article

Year

N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.

Journal of medicinal chemistry, 1994, Feb-18, Volume: 37, Issue:4

Topics: Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Blood Pressure; Half-Life; Neprilysin; Organophosphonates; Phenylalanine; Phosphopeptides; Prodrugs; Rats; Structure-Activity Relationship

1994

Quantitative analytical methods for the determination of a new hypertension drug, CGS 25462, and its metabolites (CGS 25659 and CGS 24592) in human plasma by high-performance liquid chromatography.

Journal of chromatography. B, Biomedical sciences and applications, 1998, Mar-20, Volume: 706, Issue:2

Topics: Administration, Oral; Antihypertensive Agents; Biphenyl Compounds; Chromatography, High Pressure Liquid; Circadian Rhythm; Half-Life; Humans; Male; Organophosphonates; Phenylalanine; Prodrugs; Protease Inhibitors; Reproducibility of Results; Sensitivity and Specificity; Temperature; Time Factors

1998